Pages that link to "Q52884542"
Jump to navigation
Jump to search
The following pages link to Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. (Q52884542):
Displaying 50 items.
- Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast (Q24678912) (← links)
- Association of Breast Cancer with the Finding of Atypical Ductal Hyperplasia at Core Breast Biopsy (Q30470776) (← links)
- Spectral morphometric characterization of breast carcinoma cells (Q30667426) (← links)
- Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors (Q33688929) (← links)
- Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy (Q33745658) (← links)
- DCIS grading schemes and clinical implications (Q33785753) (← links)
- The p53 tumor suppressor gene in ductal carcinoma in situ of the breast (Q33810039) (← links)
- Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy (Q33825299) (← links)
- Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients (Q33825677) (← links)
- Part III. The pathobiology of ductal carcinoma in situ (Q33987012) (← links)
- Ductal carcinoma in situ. Implications for screening mammography (Q34003496) (← links)
- Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast (Q34207931) (← links)
- Cytogenetic clues to breast carcinogenesis (Q34464929) (← links)
- Atypical Ductal Hyperplasia at the Margin of Lumpectomy Performed for Early Stage Breast Cancer: Is there Enough Evidence to Formulate Guidelines? (Q34543490) (← links)
- Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. (Q34577467) (← links)
- Lattice-based model of ductal carcinoma in situ suggests rules for breast cancer progression to an invasive state (Q34632827) (← links)
- Ductal carcinoma in situ (Q35182929) (← links)
- C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast (Q35184326) (← links)
- Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors (Q35585902) (← links)
- Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status (Q35601611) (← links)
- Validation: the new challenge for pathology (Q35812494) (← links)
- Biology and treatment of ductal carcinoma in situ (Q36731414) (← links)
- Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast (Q37210054) (← links)
- Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy (Q37406878) (← links)
- Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer (Q37445516) (← links)
- Postbiopsy Management (Q37816598) (← links)
- The challenges of integrating molecular imaging into the optimization of cancer therapy. (Q37871875) (← links)
- Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters (Q38111637) (← links)
- Formation of intracellular lumina in human prostate carcinoma (DU145) cells, maturation into signet cells, and the cribriform morphology of tumors (Q38780754) (← links)
- The need for epidemiologic studies of in-situ carcinoma of the breast (Q40445371) (← links)
- Controversies in the treatment of ductal carcinoma in situ. (Q40945856) (← links)
- The woman at high risk for breast cancer. Importance of hyperplasia (Q40975953) (← links)
- Ductal carcinoma in situ of the breast: progress and controversy. (Q41079288) (← links)
- The pathology of ductal carcinoma in situ of the breast (Q41142339) (← links)
- Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. (Q41356993) (← links)
- Ductal carcinoma in situ of the breast: Reproducibility of histological subtype analysis (Q41576208) (← links)
- A prognostic index for ductal carcinoma in situ of the breast (Q44189210) (← links)
- Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations (Q44584714) (← links)
- Differentiation between cancerous and normal hyperplastic lobules in breast lesions (Q44784071) (← links)
- Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis (Q46699535) (← links)
- Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy (Q47212783) (← links)
- Breast tumor size assessment: comparison of conventional ultrasound and contrast-enhanced ultrasound (Q47275406) (← links)
- Relationship Between the Size and Margin Status of Ductal Carcinoma In Situ of the Breast and Residual Disease (Q47302088) (← links)
- Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma (Q50650263) (← links)
- Interobserver variability in the classification of proliferative breast lesions by fine-needle aspiration: Results of the Papanicolaou Society of Cytopathology study (Q52900895) (← links)
- How to prevent invasive breast cancer: detect and excise duct carcinoma in situ. (Q53680068) (← links)
- Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy. (Q53982903) (← links)
- Prognostische Faktoren beim duktalen Carcinoma in situ (Q56638009) (← links)
- Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence (Q57159647) (← links)
- Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy (Q61970397) (← links)